Melville, NY, United States
Melville, NY, United States

Time filter

Source Type

News Article | November 2, 2016
Site: marketersmedia.com

LONDON, UK / ACCESSWIRE / November 2, 2016 / Active Wall St. announces its post-earnings coverage on The Procter & Gamble Co. (NYSE: PG). The company posted its financial results for the first quarter fiscal 2017 (Q1 FY17) on October 25, 2016. The maker of Tide detergent and Pampers diapers reported better-than-expected results, driven by strong demand for its baby, feminine and home care products Register with us now for your free membership at: http://www.activewallst.com/register/. One of Procter & Gamble's competitors within the Personal Products space, The Estee Lauder Companies, Inc. (NYSE: EL), releases its fiscal 2017 first quarter financial results today on Wednesday, November 2, 2016. AWS will be initiating a research report on Estee Lauder Companies in the coming days. Today, AWS is promoting its earnings coverage on PG; touching on EL. Get our free coverage by signing up to: For the three months ended on September 30th, 2016, P&G said net income attributable to the company rose to $2.71 billion, or $0.96 per share, from $2.60 billion, or $0.91 per share, for the same period last year. Adjusted earnings were $1.03 per share, beating analysts' estimates of $0.98 per share. The company's Q1 FY17 sales totaled $16.52 billion, marginally lower from $16.53 billion in Q1 FY16; beating the $16.48 billion analysts forecasted. Organic sales increased 3% driven by a 3% gain increase in organic shipment volume. All-in volume was up 2% for the reported quarter including the impacts of minor brand divestitures and lost sales to Venezuelan subsidiaries. During Q1 FY17, P&G's Beauty segment net sales declined 1% to $3.00 billion. Skin & Personal Care's organic sales increased due to the continued strong growth of the super-premium SK-II brand. The company's Grooming segment's sales were also down 1% to $1.66 billion in the reported quarter; however organic sales for the division increased 3% due to strong innovation-driven organic volume growth in both Shave Care and Appliances. For Q1 FY17, P&G's Health Care segment net sales were up by 4% to $1.87 billion, while organic sales for the division improved 7%, driven by double-digit growth in Personal Health Care from innovation and pricing. The Fabric & Home Care segment reported net sales of $5.30 billion, up 1%, while its organic sales increased 4% versus a year ago, driven by mid-single-digit growth in both Fabric Care and Home Care. Fabric Care organic sales growth was led by high single-digit growth in developed markets behind product innovation and marketing investments. Home Care delivered mid-single digit organic sales growth in developed and developing markets as a result of the expansion of product innovation. P&G's Baby, Feminine & Family Care segment's nets sales dropped 1% to $4.60 billion, while organic sales for the section increased 2% driven by mid-single digit organic volume growth in all three businesses. For Q1 FY17, P&G reported that its gross margin increased 30 basis points to 51.0% of net sales, including a 20 basis point increase in non-core restructuring charges. Core gross margin improved 50 basis points, including 80 basis points of negative foreign exchange impacts. The company's operating profit margin remained unchanged at 22.8% from the year ago period. Core operating profit margin increased 20 basis points versus the prior year, including 100 basis points of foreign exchange impacts. On the conference call, P&G reported that it saved over $7 billion in cost of goods sold, through its cost-reduction objectives. The company stated that it has reduced manufacturing enrollment by 22% over the last four years. This includes new staffing necessary to support capacity additions. On a same site basis, manufacturing enrollment was down 27% through last fiscal year with additional progress planned this year. P&G has reduced the number of manufacturing platforms it produces by 30% over the same period. Over the last five years, the company has reduced non-manufacturing roles by nearly 25%, excluding the impact of divestitures. P&G reported that operating cash flow was $3.0 billion for Q1 FY17. The company generated $2.3 billion in free cash flow, with 85% free cash flow productivity. Returning $2.9 billion to shareowners, $1.9 billion in dividends, and $1 billion in share repurchase. For FY17, P&G said it is maintaining its projection for organic sales growth of approximately 2%. The Company expects the combined headwinds of foreign exchange and minor brand divestitures to reduce sales growth by about 1%. The Company also maintains its expectation for core earnings per share growth of mid-single digits versus FY16 core EPS of $3.67. On Tuesday, the stock closed the trading session at $86.85, marginally up 0.06% from its previous closing price of $86.60. A total volume of 8.56 million shares have exchanged hands. Procter & Gamble's stock price advanced 1.80% in the past three months, 8.10% in the last six month, and 17.11% in the previous twelve months. Furthermore, since the start of the year, shares of the company have gained 12.96%. The stock is trading at a PE ratio of 24.90 and has a dividend yield of 3.09%. Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. AWS has not been compensated; directly or indirectly; for producing or publishing this document. The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/. For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. LONDON, UK / ACCESSWIRE / November 2, 2016 / Active Wall St. announces its post-earnings coverage on The Procter & Gamble Co. (NYSE: PG). The company posted its financial results for the first quarter fiscal 2017 (Q1 FY17) on October 25, 2016. The maker of Tide detergent and Pampers diapers reported better-than-expected results, driven by strong demand for its baby, feminine and home care products Register with us now for your free membership at: http://www.activewallst.com/register/. One of Procter & Gamble's competitors within the Personal Products space, The Estee Lauder Companies, Inc. (NYSE: EL), releases its fiscal 2017 first quarter financial results today on Wednesday, November 2, 2016. AWS will be initiating a research report on Estee Lauder Companies in the coming days. Today, AWS is promoting its earnings coverage on PG; touching on EL. Get our free coverage by signing up to: For the three months ended on September 30th, 2016, P&G said net income attributable to the company rose to $2.71 billion, or $0.96 per share, from $2.60 billion, or $0.91 per share, for the same period last year. Adjusted earnings were $1.03 per share, beating analysts' estimates of $0.98 per share. The company's Q1 FY17 sales totaled $16.52 billion, marginally lower from $16.53 billion in Q1 FY16; beating the $16.48 billion analysts forecasted. Organic sales increased 3% driven by a 3% gain increase in organic shipment volume. All-in volume was up 2% for the reported quarter including the impacts of minor brand divestitures and lost sales to Venezuelan subsidiaries. During Q1 FY17, P&G's Beauty segment net sales declined 1% to $3.00 billion. Skin & Personal Care's organic sales increased due to the continued strong growth of the super-premium SK-II brand. The company's Grooming segment's sales were also down 1% to $1.66 billion in the reported quarter; however organic sales for the division increased 3% due to strong innovation-driven organic volume growth in both Shave Care and Appliances. For Q1 FY17, P&G's Health Care segment net sales were up by 4% to $1.87 billion, while organic sales for the division improved 7%, driven by double-digit growth in Personal Health Care from innovation and pricing. The Fabric & Home Care segment reported net sales of $5.30 billion, up 1%, while its organic sales increased 4% versus a year ago, driven by mid-single-digit growth in both Fabric Care and Home Care. Fabric Care organic sales growth was led by high single-digit growth in developed markets behind product innovation and marketing investments. Home Care delivered mid-single digit organic sales growth in developed and developing markets as a result of the expansion of product innovation. P&G's Baby, Feminine & Family Care segment's nets sales dropped 1% to $4.60 billion, while organic sales for the section increased 2% driven by mid-single digit organic volume growth in all three businesses. For Q1 FY17, P&G reported that its gross margin increased 30 basis points to 51.0% of net sales, including a 20 basis point increase in non-core restructuring charges. Core gross margin improved 50 basis points, including 80 basis points of negative foreign exchange impacts. The company's operating profit margin remained unchanged at 22.8% from the year ago period. Core operating profit margin increased 20 basis points versus the prior year, including 100 basis points of foreign exchange impacts. On the conference call, P&G reported that it saved over $7 billion in cost of goods sold, through its cost-reduction objectives. The company stated that it has reduced manufacturing enrollment by 22% over the last four years. This includes new staffing necessary to support capacity additions. On a same site basis, manufacturing enrollment was down 27% through last fiscal year with additional progress planned this year. P&G has reduced the number of manufacturing platforms it produces by 30% over the same period. Over the last five years, the company has reduced non-manufacturing roles by nearly 25%, excluding the impact of divestitures. P&G reported that operating cash flow was $3.0 billion for Q1 FY17. The company generated $2.3 billion in free cash flow, with 85% free cash flow productivity. Returning $2.9 billion to shareowners, $1.9 billion in dividends, and $1 billion in share repurchase. For FY17, P&G said it is maintaining its projection for organic sales growth of approximately 2%. The Company expects the combined headwinds of foreign exchange and minor brand divestitures to reduce sales growth by about 1%. The Company also maintains its expectation for core earnings per share growth of mid-single digits versus FY16 core EPS of $3.67. On Tuesday, the stock closed the trading session at $86.85, marginally up 0.06% from its previous closing price of $86.60. A total volume of 8.56 million shares have exchanged hands. Procter & Gamble's stock price advanced 1.80% in the past three months, 8.10% in the last six month, and 17.11% in the previous twelve months. Furthermore, since the start of the year, shares of the company have gained 12.96%. The stock is trading at a PE ratio of 24.90 and has a dividend yield of 3.09%. Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. AWS has not been compensated; directly or indirectly; for producing or publishing this document. The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/. For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Matsui M.S.,The Estee Lauder Companies | Matsui M.S.,Columbia University | Pelle E.,The Estee Lauder Companies | Pelle E.,New York University | And 3 more authors.
International Journal of Molecular Sciences | Year: 2016

Circadian rhythms, ≈24 h oscillations in behavior and physiology, are reflected in all cells of the body and function to optimize cellular functions and meet environmental challenges associated with the solar day. This multi-oscillatory network is entrained by the master pacemaker located in the suprachiasmatic nucleus (SCN) of the hypothalamus, which directs an organism’s rhythmic expression of physiological functions and behavior via a hierarchical system. This system has been highly conserved throughout evolution and uses transcriptional–translational autoregulatory loops. This master clock, following environmental cues, regulates an organism’s sleep pattern, body temperature, cardiac activity and blood pressure, hormone secretion, oxygen consumption and metabolic rate. Mammalian peripheral clocks and clock gene expression have recently been discovered and are present in all nucleated cells in our body. Like other essential organ of the body, the skin also has cycles that are informed by this master regulator. In addition, skin cells have peripheral clocks that can function autonomously. First described in 2000 for skin, this review summarizes some important aspects of a rapidly growing body of research in circadian and ultradian (an oscillation that repeats multiple times during a 24 h period) cutaneous rhythms, including clock mechanisms, functional manifestations, and stimuli that entrain or disrupt normal cycling. Some specific relationships between disrupted clock signaling and consequences to skin health are discussed in more depth in the other invited articles in this IJMS issue on Sleep, Circadian Rhythm and Skin. © 2016 by the authors; licensee MDPI, Basel, Switzerland.

Loading The Estee Lauder Companies collaborators
Loading The Estee Lauder Companies collaborators